25 May 2013
Keywords: appointment, astrazeneca, glenn, gormley, joined, merck, co
Article | 05 October 2000
Glenn Gormley has joined AstraZeneca from Merck & Co to become vicepresident of clinical development for the USA.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 October 2000
4 October 2000
24 May 2013
© 2013 thepharmaletter.com